on Quantum Biopharma Ltd.
Quantum BioPharma Sues Over Alleged Stock Manipulation
Quantum BioPharma Ltd. (NASDAQ:QNTM) has filed a lawsuit in the United States District Court, alleging that CIBC World Markets, RBC Dominion Securities, and others manipulated its stock price through spoofing. The complaint claims these actions occurred between January 2020 and August 2024, resulting in damages exceeding $700 million USD.
The company asserts that the defendants repeatedly engaged in spoofing tactics, artificially depressing its stock price and harming investors. Stock prices dropped from over $460 USD in January 2020 to $7.55 USD by October 18, 2024. Legal representation will be provided by Christian Attar and Freedman Normand Friedland LLP, working on a contingency basis.
Quantum BioPharma remains open to dialogue for a resolution while investigations continue to identify other potential offenders. Additional information, including a copy of the complaint, is available on the company's website.
R. P.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Quantum Biopharma Ltd. news